Foreigners Dumped Stocks Like During the 2008 Financial Crisis | Chesley Investment Advisory Executive Director Park Se-ik

Summary

Park Se-ik and strategist Kim Hak-kyun discuss Korea's market outlook amid heavy foreign selling, biotech's high failure rates, tourism-driven consumption, and semiconductor opportunities. They recommend Samsung Biologics and active biotech ETFs for biotech exposure, Korean department stores for inbound tourism, range-trading the KOSPI, and buying memory leaders Samsung Electronics and SK hynix on cheap valuations. They also advise avoiding leveraged products and covered call ETFs at market bottoms.

• Foreign selling intensity comparable to 2008, but seen as overdone; KOSPI likely range-bound between 6000-8200.
• Biotech investing is hampered by Eroom's law; prefer Samsung Biologics as a safer CDMO and active biotech ETFs.
• Department stores Shinsegae, Lotte Shopping, and Hyundai Department Store benefit from structural growth in foreign tourist spending.
• Cover call ETFs like KODEX 200 Target Weekly Covered Call should be avoided when the market is bottoming; plain KOSPI200 ETF is better.
• Kim Hak-kyun views Samsung Electronics and SK hynix as undervalued, with long-term contracts cushioning cyclical volatility.
• Leveraged products destroy long-term returns; passive index fund investing is the more reliable path.
• US interest rate trajectory remains a key risk, but a semiconductor recovery could eventually drive KOSPI higher.